Summary
Coronary artery disease (CAD) is a global public health and socioeconomic problem that affects millions of lives each year. Percutaneous coronary interventions (PCIs) such as stenting and angioplasty have been widely adopted worldwide to treat a range of CAD indications. The market for devices used in PCI is a dynamic and competitive one that is saturated with numerous players trying to gain share by developing innovative technologies. Emerging stent technologies in the coronary stent market, including bioabsorbable stents (BASes) and the third generation of drug-eluting stents (DESes) with biodegradable polymer/polymer-free coatings, aim to address the unmet needs of treating complex lesions and challenging patient populations. This report examines the PCI market in the major South American market, Brazil.
This report provides insight into the adoption trends, market dynamics, competitive landscape, marketed and pipeline products, current and emerging players, as well as market outlooks in the South American market. The report identifies the unmet needs in the market while providing an understanding of physicians’ perceptions in using and evaluating the adoption of different types of percutaneous coronary devices.
*This is an on-demand report and will be delivered within 4 working days (excluding weekends) of the purchase.
Highlights
Key Questions Answered
- What is the current and future PCI market outlook in the developed and emerging markets? What trends are affecting the South American market?
- Which are the key, high growth markets that device manufacturers should expand into? Which markets are growing the fastest, and what are the top-selling products in each segment?
- What are the unmet needs with the current generation of devices? How will emerging technologies such as bioabsorbable stents and drug-eluting stents fulfill these unmet needs?
- What is the physician perception of these new technologies? Which indications have been treated most successfully using minimally invasive treatments?
- What are the challenges and complications that have hindered widespread adoption?
- With developing the next-generation of devices, what aspects of the technology are device manufacturers focused on optimizing? How will new entrants impact the South American PCI market?
Reasons to buy
- “What Do Physicians Think” quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information.
Companies Mentioned
Abbott Vascular
B. Braun
Biosensors International
Biotronik
Boston Scientific
Medtronic
Terumo
'
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Catalyst
2.2 Related Reports
3 Market Access
3.1 Reimbursement Trends
3.1.1 South America
3.2 Mergers and Acquisitions/Key Partnerships
4 Unmet Needs and Market Opportunity Analysis
4.1 Improving Clinical Outcomes in Complex Coronary Indications
4.1.1 Bifurcation Lesions
4.1.2 Chronic Total Occlusions
4.1.3 Heavily-calcified Lesions
4.1.4 Unprotected Left Main Coronary Artery Lesions
4.1.5 Acute Myocardial Infarction
4.1.6 Saphenous Vein Grafts
4.1.7 Small Vessel Lesions
4.2 Minimizing Late Stent Thrombosis Incidence
4.3 Procedure Optimization
4.4 Reducing Repeat Revascularization Rates
5 Competitive Assessment
5.1 Market Share Analysis
5.2 Key Companies and Product Profiles
5.2.1 Abbott Vascular
5.2.2 B. Braun
5.2.3 Biosensors International
5.2.4 Biotronik
5.2.5 Boston Scientific
5.2.6 Medtronic
5.2.7 Terumo
5.2.8 Other Players
5.3 Pipeline Products Assessment
5.4 Clinical Trials Assessment
6 Market Outlook
6.1 Procedure Trends
6.2 Global Market Drivers and Barriers
6.2.1 Driver: Rising Disease Prevalence
6.2.2 Driver: Launch of Bioabsorbable Stents on a Global Scale
6.2.3 Driver: Reducing Need for Antiplatelet Therapy
6.2.4 Barrier: Risk of Perioperative Adverse Cardiac Events Post-Stenting
6.2.5 Barrier: Post-ProceduraI Complications of Drug-Eluting Stenting
6.2.6 Barrier: Concerns Regarding Overstenting
6.3 Market Outlooks by Geography
6.3.1 South America
7 Appendix
7.1 Bibliography
7.2 Abbreviations
7.3 Methodology
7.3.1 Overview
7.3.2 Coverage
7.3.3 Secondary Research
7.4 Forecasting Methodology
7.5 Primary Research Summary
7.6 About the Authors
7.6.1 Premdharan Meyyan, Cardiovascular Analyst, Medical Devices
7.6.2 Linda Tian, Msc, Managing Analyst, Medical Devices
7.6.3 Tyler Fletcher, Global Head of Medical Devices
7.6.4 About GlobalData
7.7 Contact Us
7.8 Disclaimer
1.1 List of Tables
Table 1: Medicare National Average of Inpatient Hospital Reimbursement for Percutaneous Coronary Interventions, 2015-2016
Table 2: Hospital Outpatient Reimbursement for Percutaneous Coronary Interventions, 2015
Table 3: Key Mergers, Acquisitions, and Partnerships in Percutaneous Coronary Interventions Market
Table 4: Complex Coronary Indications and Estimated Incidence
Table 5: Abbott Vascular - Company SWOT Analysis
Table 6: Abbott Vascular - Marketed Products Assessment
Table 7: B. Braun - Company SWOT Analysis
Table 8: B. Braun - Marketed Products Assessment
Table 9: Biosensors International - Company SWOT Analysis
Table 10: Biosensors International - Marketed Products Assessment
Table 11: Biotronik - Company SWOT Analysis
Table 12: Biotronik - Marketed Products Assessment
Table 13: Boston Scientific - Company SWOT Analysis
Table 14: Boston Scientific - Marketed Products Assessment
Table 15: Medtronic - Company SWOT Analysis
Table 16: Medtronic - Marketed Products Assessment
Table 17: Terumo - Company SWOT Analysis
Table 18: Terumo - Marketed Products Assessment
Table 19: Other Players Assessment
Table 20: Pipeline Products Assessment
Table 21: Clinical Trials Assessment
Table 22: South America Percutaneous Coronary Interventions Market Forecast ($m), 2013-2022
1.2 List of Figures
Figure 1: Proportion of Patients Undergoing Repeat Revascularization, by Revascularization Subtype
Figure 2: South America Percutaneous Coronary Interventions Market Forecast ($m), by Segment, 2013-2022
Figure 3: Percutaneous Coronary Survey Primary Research Participants, by Country
